Jupiter Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Jupiter Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$24.8M	Sell	421,952 -60,985	-13%	-$3.65M	0.4%	78
2020 Q1	$26.9M	Sell	482,937 -185,437	-28%	-$11.3M	0.52%	58
2019 Q4	$42.9M	Buy	668,374 +606,290	+977%	+$34.7M	0.59%	49
2019 Q3	$3.15M	Sell	62,084 -1,080,002	-95%	-$50.8M	0.04%	280
2019 Q2	$51.8M	Sell	1,142,086 -3,496,833	-75%	-$163M	0.53%	71
2019 Q1	$221M	Buy	4,638,919 +508,483	+12%	+$25.3M	2.04%	5
2018 Q4	$215M	Buy	4,130,436 +4,063,712	+6,090%	+$218M	1.9%	9
2018 Q3	$4.14M	Sell	66,724 -1,200,293	-95%	-$71.2M	0.03%	199
2018 Q2	$70.1M	Buy	+1,267,017	New	+$68.4M	0.5%	66
2018 Q1	–	Sell	-481,140	Closed	-$29.5M	–	370
2017 Q4	$29.5M	Buy	+481,140	New	+$30.1M	0.27%	92
2016 Q4	–	Sell	-3,076	Closed	-$165K	–	368
2016 Q3	$165K	Buy	+3,076	New	+$198K	﹤0.01%	319
2015 Q4	–	Sell	-88,193	Closed	-$5.22M	–	291
2015 Q3	$5.22M	Buy	+88,193	New	+$5.59M	0.15%	133
2015 Q2	–	Sell	-26,600	Closed	-$1.72M	–	284
2015 Q1	$1.72M	Buy	+26,600	New	+$1.67M	0.05%	179

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jupiter Investment Management's BMY Position: Q2 2020 in Review

Jupiter Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2020, selling an estimated $3.65M and leaving 421,952 shares worth $24.8M. The position accounts for 0.4% of the portfolio, ranked #78.

Jupiter Investment Management first reported a position in BMY in Q1 2015 and has held it in 13 quarters since. The position peaked at $221M in Q1 2019. 2,189 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

Jupiter Investment Management held 421,952 shares of Bristol-Myers Squibb worth $24.8M as of Q2 2020.
Jupiter Investment Management sold 60,985 Bristol-Myers Squibb shares in Q2 2020, an estimated $3.65M.
Bristol-Myers Squibb made up 0.4% of Jupiter Investment Management's portfolio in Q2 2020, its #78 holding.
Jupiter Investment Management first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 13 quarters since.
Jupiter Investment Management's Bristol-Myers Squibb position peaked at $221M in Q1 2019.
2,189 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.